Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Utilization, effect, and benefit of the individualized Meeting Centers Support Program for people with dementia and caregivers

Dröes RM, van Rijn A, Rus E, Dacier S, Meiland F.

Clin Interv Aging. 2019 Aug 26;14:1527-1553. doi: 10.2147/CIA.S212852. eCollection 2019.

Rare case offers clues to staving off Alzheimer's

Servick K.

Science. 2019 Nov 8;366(6466):674. doi: 10.1126/science.366.6466.674.

Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease

Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S.

J Alzheimers Dis. 2019;72(4):1313-1322. doi: 10.3233/JAD-190791.

Alzheimer's disease

Soria Lopez JA, González HM, Léger GC.

Handb Clin Neurol. 2019;167:231-255. doi: 10.1016/B978-0-12-804766-8.00013-3.

Salvage of the retinal ganglion cells in transition phase in Alzheimer's disease with topical coenzyme Q10: is it possible?

Karakahya RH, Özcan TŞ.

Graefes Arch Clin Exp Ophthalmol. 2020 Feb;258(2):411-418. doi: 10.1007/s00417-019-04544-3. Epub 2019 Nov 28.

Cognitive symptoms of Alzheimer's disease: clinical management and prevention

Joe E, Ringman JM.

BMJ. 2019 Dec 6;367:l6217. doi: 10.1136/bmj.l6217.

Current and Emerging Solutions to Challenges in the Management of Alzheimer's Disease

Atri A, Goldfarb D, Sheard S, Shaughnessy L.

J Clin Psychiatry. 2019 Dec 3;80(6):MS18002AH3C. doi: 10.4088/JCP.MS18002AH3C.

Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies

Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D.

Ageing Res Rev. 2020 Mar;58:101001. doi: 10.1016/j.arr.2019.101001. Epub 2019 Dec 20.

Why Not a Global Postural Reeducation as an Alternative Therapy Applied to Alzheimer's Patients in Nursing Homes? A Pioneer Randomized Controlled Trial

Todri J, Todri A, Lena O.

Dement Geriatr Cogn Disord. 2019;48(3-4):172-179. doi: 10.1159/000505397. Epub 2020 Jan 31.

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases

Páez JA, Campillo NE.

Curr Med Chem. 2019;26(18):3300-3340. doi: 10.2174/0929867325666180226095132.

Alzheimer's Disease: Physical Activities as an Effective Intervention Tool - A Mini-Review

Klimova B, Maresova P, Kuca K.

Curr Alzheimer Res. 2019;16(2):166-171. doi: 10.2174/1567205015666181002132021.

Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E, Khachaturian ZS.

J Prev Alzheimers Dis. 2019;6(1):2-15. doi: 10.14283/jpad.2018.43.

The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: A systematic review and meta-analysis

Lin Y, Jiang WJ, Shan PY, Lu M, Wang T, Li RH, Zhang N, Ma L.

J Neurol Sci. 2019 Mar 15;398:184-191. doi: 10.1016/j.jns.2019.01.038. Epub 2019 Jan 24.

Natural and Synthetic Cannabinoids for Agitation and Aggression in Alzheimer's Disease: A Meta-Analysis

Ruthirakuhan M, Lanctôt KL, Vieira D, Herrmann N.

J Clin Psychiatry. 2019 Jan 29;80(2):18r12617. doi: 10.4088/JCP.18r12617.

Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease

Gul A, Bakht J, Mehmood F.

J Chin Med Assoc. 2019 Jan;82(1):40-43. doi: 10.1016/j.jcma.2018.07.004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias